These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 29348263)

  • 1. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
    Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
    Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling the metabolic rewiring in the context of doxorubicin-induced cardiotoxicity: Fuel preference changes from fatty acids to glucose oxidation.
    Guerra G; Russo M; Priolo R; Riganti C; Reano S; Filigheddu N; Hirsch E; Ghigo A
    Vascul Pharmacol; 2024 Jun; 155():107324. PubMed ID: 38985581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
    Zheng D; Zhang Y; Zheng M; Cao T; Wang G; Zhang L; Ni R; Brockman J; Zhong H; Fan GC; Peng T
    Clin Sci (Lond); 2019 Jul; 133(13):1505-1521. PubMed ID: 31266854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
    Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marein Alleviates Doxorubicin-Induced Cardiotoxicity through FAK/AKT Pathway Modulation while Potentiating its Anticancer Activity.
    Xu J; Lv M; Ni X
    Cardiovasc Toxicol; 2024 Aug; 24(8):818-835. PubMed ID: 38896162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclin-dependent kinase 7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy.
    Chen J; Wei J; Xia P; Liu Y; Belew MD; Toohill R; Wu BJ; Cheng Z
    Cardiovasc Res; 2024 Jul; 120(9):1024-1036. PubMed ID: 38646672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38δ genetic ablation protects female mice from anthracycline cardiotoxicity.
    George SA; Kiss A; Obaid SN; Venegas A; Talapatra T; Wei C; Efimova T; Efimov IR
    Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H775-H786. PubMed ID: 32822209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT
    Huang CY; Chen JY; Kuo CH; Pai PY; Ho TJ; Chen TS; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Jan; 233(1):463-475. PubMed ID: 28295305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of autophagy in doxorubicin-induced cardiotoxicity.
    Dirks-Naylor AJ
    Life Sci; 2013 Dec; 93(24):913-6. PubMed ID: 24404586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary cyanidin 3-glucoside from purple corn ameliorates doxorubicin-induced cardiotoxicity in mice.
    Petroni K; Trinei M; Fornari M; Calvenzani V; Marinelli A; Micheli LA; Pilu R; Matros A; Mock HP; Tonelli C; Giorgio M
    Nutr Metab Cardiovasc Dis; 2017 May; 27(5):462-469. PubMed ID: 28428026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
    Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
    Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
    Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
    Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3Kγ inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanism.
    Carnevale D; Vecchione C; Mascio G; Esposito G; Cifelli G; Martinello K; Landolfi A; Selvetella G; Grieco P; Damato A; Franco E; Haase H; Maffei A; Ciraolo E; Fucile S; Frati G; Mazzoni O; Hirsch E; Lembo G
    Cardiovasc Res; 2012 Jan; 93(1):200-9. PubMed ID: 22038741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
    Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
    Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity.
    Durrant DE; Das A; Dyer S; Tavallai S; Dent P; Kukreja RC
    Mol Pharmacol; 2015 Sep; 88(3):512-23. PubMed ID: 26101222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.